DEA Revokes Veterinarian's Controlled Substance Registrations

You might care about this because the Drug Enforcement Administration, or DEA, has decided to revoke the controlled substance registrations of veterinarian Kerri Zavota, DVM. She is located in South Daytona, Florida. The DEA initially sent her an Order to Show Cause, or OSC, on December 15, 2025. This document proposed taking away her two DEA registrations and denying any attempts to renew them. The main reasons given were that she supposedly provided false information on her DEA renewal applications and did not keep complete and accurate records when dealing with controlled substances. The DEA said her continued registration was not in the public interest. The legal process involved the DEA serving the OSC to Dr. Zavota on December 18, 2025. She then had 30 days to ask for a hearing and respond to the accusations. However, she did not do so. Because she failed to respond within the required timeframe, she was considered to be in "default." According to DEA rules, being in default means she gave up her right to a hearing. It also means she is considered to have admitted that the factual allegations in the OSC are true. The DEA noted that even after 45 days, she did not ask to be excused from this default. The Controlled Substances Act, or CSA, aims to prevent drug abuse and control how controlled substances are handled legally and illegally. It sets strict rules for registration and record-keeping to stop drugs from being diverted from legal uses to illegal ones. The DEA needed to prove its case. Since Dr. Zavota defaulted, the DEA did not need to present further evidence for the "public interest" part. Instead, they focused on the material falsification claims. The agency explained that material falsification means an application was submitted with a false statement or missing important information, the person knew or should have known it was false or missing, and this false information or omission could affect the DEA's decision. The document ends by stating that Dr. Zavota had answered "Yes" to a question about her professional license history on an application, explaining a previous issue with the Florida Department of Business and Professional Regulations. This case is particularly interesting because it clearly shows what happens when a medical professional does not respond to a formal notice from a regulatory body like the DEA. Dr. Zavota's failure to request a hearing or respond to the Order to Show Cause resulted in a "default." This default had a direct and clear outcome. It meant she legally admitted to all the factual claims made by the DEA. This includes the serious allegations of materially falsifying her DEA renewal applications and failing to keep proper records for controlled substances. This situation highlights how important it is for anyone with a DEA registration to engage with the administrative process. Ignoring such notices can lead to severe consequences, as seen here with the revocation of her registrations. The ruling also clarifies the DEA's power under the Controlled Substances Act, or CSA. It reminds all registrants that strict adherence to application honesty and record-keeping rules is not just a suggestion but a legal requirement. The DEA's definition of "material falsification" is also important. It requires that the false statement or missing information must be something that could influence the DEA's decision about a registration. This specific case shows that the DEA considers a registrant's history and transparency in their applications to be fundamental to the public interest. It reinforces the idea that even if a registrant has had past issues, how they report those issues on official forms is extremely important. The results of misrepresentation, whether intended or not, can be very serious. Many groups and individuals would find this legal document highly relevant. First, any veterinarian, doctor, dentist, or other healthcare professional who holds a DEA registration to prescribe or dispense controlled substances should pay close attention. This includes pharmacists, nurses, and researchers as well. The document directly affects their professional practices and responsibilities. It serves as a strong reminder about the importance of accurate reporting on DEA applications and maintaining precise records for controlled substances. Additionally, legal professionals, such as attorneys specializing in administrative law, healthcare law, or drug enforcement defense, would find this case valuable. It provides a real-world example of DEA enforcement procedures, including the "default" mechanism and its implications. State and federal regulatory bodies, particularly those overseeing professional licensing and controlled substance programs, could use this as a reference. They might use it to understand how the DEA handles alleged violations. Students of law or public policy who are studying drug enforcement, administrative procedure, or professional ethics would also find the case useful. Finally, veterinary associations and medical boards might share this information with their members to educate them about compliance requirements and the potential penalties for not following regulations. It helps clarify the standards expected of all registrants in the medical field.